This is all very good dma but the trials and implants are what...

This is all very good dma but the trials and implants are what will drive the SP IMO.

Also, VCR has stated that they are working on getting reimbursements from other countries especially in Europe as the device is approved in the EU.

Asian expansion is also a very positive step although I think they will be limited at this stage as they are diverting most of their resources into the US trials.

Bring on more centers and get unconditional DT approval....this is what they need to do and quickly.

All momentum looks gone from two weeks ago. Oh well, thats the way it goes. I'm looking to accumulate on any more weakness and have another buy in at 60c.

News to follow;
1. DT Trial unconditional approval
2. More centers on board
3. 200 implants reached
4. Reimbursement approved in new countries
5. Approval to use LVAD4 in US trials

Any others ??